Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
2.700
+0.020 (0.75%)
At close: Apr 24, 2026, 4:00 PM EDT
2.750
+0.050 (1.85%)
After-hours: Apr 24, 2026, 4:49 PM EDT
Exagen Market Cap
Exagen has a market cap or net worth of $64.94 million as of April 24, 2026. Its market cap has decreased by -17.53% in one year.
Market Cap
64.94M
Enterprise Value
60.39M
1-Year Change
-17.53%
Ranking
Category
Stock Price
$2.70
Market Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $64.94M, an increase of 2.91%. That is a compound annual growth rate of 0.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 64.94M | -52.87% |
| Dec 31, 2025 | 137.79M | 90.55% |
| Dec 31, 2024 | 72.31M | 113.18% |
| Dec 29, 2023 | 33.92M | -13.39% |
| Dec 30, 2022 | 39.17M | -79.17% |
| Dec 31, 2021 | 187.99M | 12.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Myriad Genetics | 430.66M |
| Prenetics Global | 296.60M |
| Burning Rock Biotech | 224.54M |
| FONAR | 123.28M |
| Insight Molecular Diagnostics | 113.55M |
| MDxHealth | 112.98M |
| Biodesix | 105.87M |
| Precipio | 49.05M |